SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ellingsen K.)
 

Search: WFRF:(Ellingsen K.) > Biomaterials and re...

Biomaterials and regenerative technologies used in bone regeneration in the craniomaxillofacial region: Consensus report of group 2 of the 15th European Workshop on Periodontology on Bone Regeneration

Sanz, M. (author)
Dahlin, Christer, 1959 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för biomaterialvetenskap,Institute of Clinical Sciences, Department of Biomaterials
Apatzidou, D. (author)
show more...
Artzi, Z. (author)
Bozic, D. (author)
Calciolari, E. (author)
De Bruyn, H. (author)
Dommisch, H. (author)
Donos, N. (author)
Eickholz, P. (author)
Ellingsen, J. E. (author)
Haugen, H. J. (author)
Herrera, D. (author)
Lambert, F. (author)
Layrolle, P. (author)
Montero, E. (author)
Mustafa, K. (author)
Omar, O. (author)
Schliephake, H. (author)
show less...
 (creator_code:org_t)
2019-06-18
2019
English.
In: Journal of Clinical Periodontology. - : Wiley. - 0303-6979. ; 46, s. 82-91
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and Aims To review the regenerative technologies used in bone regeneration: bone grafts, barrier membranes, bioactive factors and cell therapies. Material and Methods Four background review publications served to elaborate this consensus report. Results and Conclusions Biomaterials used as bone grafts must meet specific requirements: biocompatibility, porosity, osteoconductivity, osteoinductivity, surface properties, biodegradability, mechanical properties, angiogenicity, handling and manufacturing processes. Currently used biomaterials have demonstrated advantages and limitations based on the fulfilment of these requirements. Similarly, membranes for guided bone regeneration (GBR) must fulfil specific properties and potential biological mechanisms to improve their clinical applicability. Pre-clinical and clinical studies have evaluated the added effect of bone morphogenetic proteins (mainly BMP-2) and autologous platelet concentrates (APCs) when used as bioactive agents to enhance bone regeneration. Three main approaches using cell therapies to enhance bone regeneration have been evaluated: (a) "minimally manipulated" whole tissue fractions; (b) ex vivo expanded "uncommitted" stem/progenitor cells; and (c) ex vivo expanded "committed" bone-/periosteum-derived cells. Based on the evidence from clinical trials, transplantation of cells, most commonly whole bone marrow aspirates (BMA) or bone marrow aspirate concentrations (BMAC), in combination with biomaterial scaffolds has demonstrated an additional effect in sinus augmentation and horizontal ridge augmentation, and comparable bone regeneration to autogenous bone in alveolar cleft repair.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Odontologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dentistry (hsv//eng)

Keyword

barrier membrane
bio-absorbable
bioactive agent
biomaterials
bone regeneration
bone
Dentistry
Oral Surgery & Medicine

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view